|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Departments of 1Intensive Care Medicine, 3Anesthesiology, 4Pulmonology, and 6Experimental Immunology, Academic Medical Center, and 2Laboratory of Experimental Intensive Care and Anesthesiology (LEICA), Amsterdam, The Netherlands; 5Unit of Industrial Toxicology and Occupational Medicine, Department of Public Health, Catholic University of Louvain, Brussels, Belgium
Submitted 10 July 2007 ; accepted in final form 10 December 2007
Clara cell protein levels are elevated in plasma of individuals with mild or subclinical lung injury. We studied the influence of two mechanical ventilation strategies on local and systemic levels of Clara cell protein (CC16) and compared them with levels of soluble receptor for advanced glycation end products (sRAGE) and surfactant proteins (SP)-A and -D in patients undergoing elective surgery. Saved samples from a previously reported investigation were used for the study. Forty patients planned for elective surgery were randomized to mechanical ventilation with either a conventional tidal volume (VT) of 12 ml/kg without positive end-expiratory pressure (PEEP) or low VT of 6 ml/kg and 10 cmH2O PEEP. Plasma and bronchoalveolar lavage fluid (BALF) was collected directly after intubation and after 5 h of mechanical ventilation. While systemic levels of SP-A and SP-D remained unchanged, systemic levels of CC16 and sRAGE increased significantly in both groups after 5 h (P < 0.001 for both). BALF levels of SP-A, SP-D, CC16, and sRAGE remained unaffected. No differences were found between the two mechanical ventilation strategies regarding any of the measured biological markers. In conclusion, systemic levels of CC16 and sRAGE rise after 5 h in patients receiving mechanical ventilation for elective surgery. Mechanical ventilation with lower tidal volumes and PEEP did not have a different effect on levels of biomarkers of lung epithelial injury compared with conventional mechanical ventilation.
Clara cell protein; receptor for advanced glycation end products; pulmonary inflammation
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |